This study investigated the effects of ionic dissolution products released from dicalcium silicate (DS) coatings on human mesenchymal stem cells (hMSC), cultured in the presence or absence of the dissolution products, with or without osteogenic supplements (OS). DS+ medium promoted cell proliferation during the first 4 days, but then inhibited proliferation. DS+OS− medium increased alkaline phosphatase (ALP) activity on day 14, and upregulated runt-related transcription factor 2 and osteonectin mRNA on days 7 and 14, respectively. The addition of osteogenic supplements (DS+OS+) led to a significant increase in ALP activity from days 7 to 21, upregulation of osteogenic markers on day 14, and formation of more mineralized nodules on day 28. The results demonstrated that the ionic dissolution products from DS coating alone can partly induce osteogenic differentiation of hMSC, and that the addition of osteogenic supplements further enhances osteoblast-specific gene expression and mineralization in hMSC.
KondoNOgoseATokunagaK: Osteoinduction with highly purified β-tricalcium phosphate in dog dorsal muscles and the proliferation of osteoclasts before heterotopic bone formation. Biomaterials2006; 27: 4419–4427.
2.
WalboomersXFJansenJA: Bone tissue induction, using a COLLOSS-filled titanium fibre mesh-scaffolding material. Biomaterials2005; 26: 4779–4785.
3.
HabibovicPde GrootK: Osteoinductive biomaterials–properties and relevance in bone repair. J Tissue Eng Regen Med2007; 1: 25–32.
4.
LappalainenRSantavirtaSS: Potential of coatings in total hip replacement. Clin Orthop Relat Res2005; 430: 72–79.
5.
GeethaMSinghAKAsokamaniR: Ti based biomaterials, the ultimate choice for orthopaedic implants–a review. Prog Mater Sci2009; 54: 397–425.
6.
MaloneyWJWoolsonST: Increasing incidence of femoral osteolysis in association with uncemented Harris–Galante total hip arthroplasty. A follow-up report. J Arthroplasty1996; 11: 130–134.
7.
MichiardiAAparicioCRatnerBD: The influence of surface energy on competitive protein adsorption on oxidized NiTi surfaces. Biomaterials2007; 28: 586–594.
8.
ZhangELZouCMZengSY: Preparation and characterization of silicon-substituted hydroxyapatite coating by a biomimetic process on titanium substrate. Surf Coat Technol2009; 203: 1075–1080.
9.
MouzinOSoballeKBechtoldJE: Loading improves anchorage of hydroxyapatite implants more than titanium implants. J Biomed Mater Res2001; 58: 61–68.
10.
NeleaVMorosanuCIliescuM: Hydroxyapatite thin films grown by pulsed laser deposition and radio-frequency magnetron sputtering: Comparative study. Appl Surf Sci2004; 228: 346–356.
11.
InagakiMKameyamaT: Phase transformation of plasma-sprayed hydroxyapatite coating with preferred crystalline orientation. Biomaterials2007; 28: 2923–2931.
12.
LiXWengJTongW: Characterization of hydroxyapatite film with mixed interface by Ar+ ion beam enhanced deposition. Biomaterials1997; 18: 1487–1493.
13.
AlbayrakOEl-AtwaniOAltintasS: Hydroxyapatite coating on titanium substrate by electrophoretic deposition method: Effects of titanium dioxide inner layer on adhesion strength and hydroxyapatite decomposition. Surf Coat Technol2008; 202: 2482–2487.
14.
HanJYYuZTZhouL: Hydroxyapatite/titania composite bioactivity coating processed by the sol–gel method. Biomed Mater2008; 3: 044109 [E-pub 2008 Nov 25].
15.
SunLBerndtCCGrossKA: Material fundamentals and clinical performance of plasma-sprayed hydroxyapatite coatings: A review. J Biomed Mater Res2001; 58: 570–592.
16.
D'AntonioJACapelloWNManleyMT: Hydroxyapatite femoral stems for total hip arthroplasty: 10- to 13-year follow-up. Clin Orthop Relat Res2001; 393: 101–111.
17.
YangYCChangELeeSY: Mechanical properties and Young's modulus of plasma-sprayed hydroxyapatite coating on Ti substrate in simulated body fluid. J Biomed Mater Res2003; 67: 886–899.
18.
LaiKAShenWJChenCH: Failure of hydroxyapatite-coated acetabular cups: Ten-year follow-up of 85 Landos Atoll arthroplasties. J Bone Joint Surg Br2002; 84: 641–646.
19.
FathiMHDoostmohammadiA: Bioactive glass nanopowder and bioglass coating for biocompatibility improvement of metallic implant. J Mater Process Tech2009; 209: 1385–1391.
ZhengXHuangMDingC: Bond strength of plasma-sprayed hydroxyapatite/Ti composite coatings. Biomaterials2000; 21: 841–849.
25.
LiuXXieYDingC: Early apatite deposition and osteoblast growth on plasma-sprayed dicalcium silicate coating. J Biomed Mater Res A2005; 74: 356–365.
26.
SunJWeiLLiuX: Influences of ionic dissolution products of dicalcium silicate coating on osteoblastic proliferation, differentiation and gene expression. Acta Biomater2009; 5: 1284–1293.
27.
SunJLiJLiuX: Proliferation and gene expression of osteoblasts cultured in DMEM containing the ionic products of dicalcium silicate coating. Biomed Pharmacother2009; 63: 650–657.
28.
TognariniISoraceSZonefratiR: In vitro differentiation of human mesenchymal stem cells on Ti6Al4V surfaces. Biomaterials2008; 29: 809–824.
29.
WeissenboeckMSteinEUndtG: Particle size of hydroxyapatite granules calcified from red algae affects the osteogenic potential of human mesenchymal stem cells in vitro. Cells Tissues Organs2006; 182: 79–88.
30.
PittengerMFMackayAMBeckSC: Multilineage potential of adult human mesenchymal stem cells. Science1999; 284: 143–147.
31.
DucyPZhangRGeoffroyV: Osf2/Cbfa1: A transcriptional activator of osteoblast differentiation. Cell1997; 89: 747–754.
32.
LeeKSKimHJLiQL: Runx2 is a common target of transforming growth factor β1 and bone morphogenetic protein 2, and cooperation between Runx2 and Smad5 induces osteoblast-specific gene expression in the pluripotent mesenchymal precursor cell line C2C12. Mol Cell Biol2000; 20: 8783–8792.
33.
ZhuJXSasanoYTakahashiI: Temporal and spatial gene expression of major bone extracellular matrix molecules during embryonic mandibular osteogenesis in rats. Histochem J2001; 33: 25–35.
34.
BradfordMM: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem1976; 72: 248–254.
35.
ChaudharyLRHofmeisterAMHruskaKA: Differential growth factor control of bone formation through osteoprogenitor differentiation. Bone2004; 34: 402–411.
36.
ValerioPPereiraMMGoesAM: The effect of ionic products from bioactive glass dissolution on osteoblast proliferation and collagen production. Biomaterials2004; 25: 2941–2948.
37.
GoughJEJonesJRHenchLL: Nodule formation and mineralisation of human primary osteoblasts cultured on a porous bioactive glass scaffold. Biomaterials2004; 25: 2039–2046.
38.
SteinGSLianJBSteinJL: Transcriptional control of osteoblast growth and differentiation. Physiol Rev1996; 76: 593–629.
39.
ChengSLYangJWRifasL: Differentiation of human bone marrow osteogenic stromal cells in vitro: induction of the osteoblast phenotype by dexamethasone. Endocrinology1994; 134: 277–286.
40.
MaromRShurISolomonR: Characterization of adhesion and differentiation markers of osteogenic marrow stromal cells. J Cell Physiol2005; 202: 41–48.
41.
JaiswalNHaynesworthSECaplanAI: Osteogenic differentiation of purified, culture-expanded human mesenchymal stem cells in vitro. J Cell Biochem1997; 64: 295–312.
42.
OwenTAAronowMShalhoubV: Progressive development of the rat osteoblast phenotype in vitro: reciprocal relationships in expression of genes associated with osteoblast proliferation and differentiation during formation of the bone extracellular matrix. J Cell Physiol1990; 143: 420–430.
43.
BeresfordJNGravesSESmoothyCA: Formation of mineralized nodules by bone derived cells in vitro: a model of bone formation?Am J Med Genet1993; 45: 163–178.
44.
MalavalLModrowskiDGuptaAK: Cellular expression of bone-related proteins during in vitro osteogenesis in rat bone marrow stromal cell cultures. J Cell Physiol1994; 158: 555–572.
45.
KomoriT: Runx2, a multifunctional transcription factor in skeletal development. J Cell Biochem2002; 87: 1–8.
46.
OttoFThornellAPCromptonT: Cbfa1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development. Cell1997; 89: 765–771.
47.
BruderSPJaiswalNHaynesworthSE: Growth kinetics, self-renewal, and the osteogenic potential of purified human mesenchymal stem cells during extensive subcultivation and following cryopreservation. J Cell Biochem1997; 64: 278–294.
48.
LynchMPSteinJLSteinGS: The influence of type I collagen on the development and maintenance of the osteoblast phenotype in primary and passaged rat calvarial osteoblasts: Modification of expression of genes supporting cell growth, adhesion, and extracellular matrix mineralization. Exp Cell Res1995; 216: 35–45.
49.
BouletreauPJWarrenSMLongakerMT: The molecular biology of distraction osteogenesis. J Craniomaxillofac Surg2002; 30: 1–11.
50.
HauschkaPVWiansFHJr: Osteocalcin– hydroxyapatite interaction in the extracellular organic matrix of bone. Anat Rec1989; 224: 180–188.
51.
FranceschiRT: The developmental control of osteoblast-specific gene expression: Role of specific transcription factors and the extracellular matrix environment. Crit Rev Oral Biol Med1999; 10: 40–57.
52.
BoskeyALGadaletaSGundbergC: Fourier transform infrared microspectroscopic analysis of bones of osteocalcin-deficient mice provides insight into the function of osteocalcin. Bone1998; 23: 187–196.
